... (15) successfully attract and retain collaborative partners, (16) successfully commercialize and gain market acceptance for its Keflex products, ...
all 8 news articles
The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily ...
The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily ...
The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily ...
all 11 news articles
One of these involved selling to a major shareholder, Deerfield Management, US rights to the first-generation cephalosporin antibiotic Keflex (cephalexin), ...
The company currently markets Keflex, a cephalexin product the firm acquired in June 2004 from Indianapolis-based Eli Lilly and Co., Bannon said. ...
The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily ...
The company's pulsatile product candidates include Amoxicillin PULSYS for adults and adolescents with pharyngitis and/or tonsillitis; and Keflex PULSYS ...